GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Siegfried Holding AG (OTCPK:SGFEF) » Definitions » Valuation Rank

SGFEF (Siegfried Holding AG) Valuation Rank


View and export this data going back to 2014. Start your Free Trial

What is Siegfried Holding AG Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Siegfried Holding AG Valuation Rank Related Terms

Thank you for viewing the detailed overview of Siegfried Holding AG's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Siegfried Holding AG Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Siegfried Holding AG (OTCPK:SGFEF) » Definitions » Valuation Rank
Comparable Companies
XSWX:PPGN XSWX:CURN XSWX:SDZ ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD HKSE:03692 NSE:DIVISLAB XTAE:TEVA SHSE:688506 TSE:4507 BOM:500087 SZSE:000538 NSE:TORNTPHARM UTHR BOM:500124 NBIX
Traded in Other Exchanges
SFZNz:UK 0QQO:UK SQG0:Germany SFZN:Switzerland
Address
Untere Bruehlstrasse 4, Zofingen, CHE, CH-4800
Website
https://www.siegfried.ch
Siegfried is a global contract development and manufacturing organization. It derives its revenue primarily from long-term supply agreements with biotechnology and pharmaceutical customers. Siegfried develops and manufactures active pharmaceutical ingredients, finished dosage forms (tablets, capsules, sterile vials, ampules, cartridges, and ointments), and viral vectors. The company provides these services throughout the entire drug lifecycle, including chemical and analytical development, pilot manufacturing, and commercial-scale manufacturing. Siegfried has a large global footprint with 13 production sites on three continents.